New model maps how dialysis fluid breaks down in kidney patients
Researchers have created a mathematical model tracking how icodextrin—a key component in peritoneal dialysis fluid—degrades during treatment. The work could help optimize dialysis protocols and improve outcomes for the millions of kidney patients worldwide who rely on this therapy, potentially reducing treatment time and improving efficiency.
Originaltitel: Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis
<title>Abstract</title><p>In peritoneal dialysis, ultrafiltration is achieved by adding an osmotic agent into the dialysis fluid. During an exchange with icodextrin-based solution, polysaccharide chains are degraded by α-amylase activity in dialysate, influencing its osmotic properties. We modelled water and solute removal taking into account degradation by α-amylase and absorption of icodextrin from the peritoneal cavity. We analysed data from 16-hour dwells with icodextrin-based solution in 11 patients (8 icodextrin-naïve, 3 icodextrin-exposed) on dialysate volume, dialysate concentrations of glucose, urea, creatinine and α-amylase, and dialysate and blood concentrations of 7 icodextrin molecular weight fractions. The three-pore model was extended to describe hydrolysis of icodextrin by α-amylase. The extended model accurately predicted kinetics of ultrafiltration, small solutes and icodextrin fractions in dialysate, indicating differences in degradation kinetics between icodextrin-naïve and icodextrin-exposed patients. In addition, the model provided information on the patterns of icodextrin degradation caused by α-amylase. Modelling of icodextrin kinetics using a modified three-pore model that takes into account absorption of icodextrin and changes in α-amylase activity in the dialysate provided accurate description of peritoneal transport and information on patterns of icodextrin hydrolysis during long icodextrin dwells.</p>